Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Late Risedronate After Hemiarthroplasty
NCT02148848Phase 4Unknown
- Sponsor
- Mahidol University
- Start
- Jun 2013
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of risedronate in osteoporosis (2 arms), sponsored by Mahidol University. Primary endpoint: de Morton Mobility Index at 3 months. Status: unknown.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02148848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02148848.